Dr. John Robbins, Died at 86, Saved Millions

  • Thread starter Thread starter BillTre
  • Start date Start date
Click For Summary
SUMMARY

Dr. John Robbins, a prominent figure in vaccine development, passed away at the age of 86 due to prostate cancer. He is renowned for creating a method that significantly improved the effectiveness of the Hib (Haemophilus influenzae type b) meningitis vaccine for infants, reducing the incidence of the disease from over a thousand deaths per day to nearly non-existent in the U.S. His innovative approach involved linking an antigen to a polysaccharide, a technique that has also been applied to enhance vaccines for other diseases. Robbins dedicated his career to research at the NIH without seeking personal profit from his groundbreaking discoveries.

PREREQUISITES
  • Understanding of vaccine development processes
  • Knowledge of immunology, specifically the role of antigens and polysaccharides
  • Familiarity with the history of Hib meningitis and its impact on public health
  • Awareness of ethical considerations in biomedical research and patenting
NEXT STEPS
  • Research the mechanisms of antigen-polysaccharide conjugate vaccines
  • Study the historical impact of Hib meningitis and vaccination strategies
  • Explore the ethical implications of patenting in biomedical research
  • Investigate the contributions of Dr. Rachel Schneerson to vaccine development
USEFUL FOR

Public health professionals, vaccine researchers, medical historians, and anyone interested in the ethical dimensions of biomedical innovation will benefit from this discussion.

BillTre
Science Advisor
Gold Member
Messages
2,741
Reaction score
11,986
Dr. John Robbins (a giant whom I never heard of before), developed methods for making better vaccines, died last month of prostate cancer.

Screen Shot 2019-12-20 at 3.42.40 PM.png


His big development was a new way to make a Hib (Haemophilus influenzae type b) meningitis vaccine effective in young babies.
Prior to the vaccine, Hib meningitis once killed more than a thousand infants a day worldwide.
Now the rate is almost non-existent in the US, only about one case of Hib meningitis a year for every million children under age 5.
The method he and his collaborators developed, linking an antigen to a polysaccharide, was also used to make improved vaccines against other diseases.

He worked at the NIH and never profited from his discoveries. Now-a-days, any such advance would be immediately patented by the institute it was developed in.

NY Times obituary here.
 
  • Like
Likes   Reactions: sysprog, chemisttree, jedishrfu and 10 others
Biology news on Phys.org

Similar threads

  • · Replies 1 ·
Replies
1
Views
4K